FLUOROURACIL Labatec 250 mg/5ml flac 5 ml
7680656880015
CH-65688
L01BC02
07.16.1.
1 / 3
google
Details
- Product number
- 6568801
- CPT
- -
- Packaging group
- 1
- Unit
- Durchstechflasche(n)
- Composition
- fluorouracilum 250 mg, trometamolum, natrii hydroxidum corresp. natrium 31.6 mg, aqua ad iniectabile q.s. ad solutionem pro 5 ml.
Articles (1)
Fluorouracil Labatec 250 mg/5 ml, Solution injectable/pour perfusion
Lösung
1
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
250.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
31.6 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
Reimbursement information
Public price
CHF 12.45
Specialties list
Yes
Generic
Yes
SL addition date:
01/12/2017
Authorization holder
Labatec Pharma SA
1217 Meyrin
Authorization information
- Swissmedic authorization number
- 65688
- Drug name
- Fluorouracil Labatec, Solution injectable/pour perfusion
- Galenic form
- LSIN
- ATC Code
- L01BC02
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 31/03/2016
- Authorization expiration date
- 31/12/9999
- IT number
- 07.16.1.
- Domain
- Human medicine
Packaging details
- Description (FR)
- FLUOROURACIL Labatec 250 mg/5ml flac 5 ml
- Description (DE)
- FLUOROURACIL Labatec 250 mg/5ml Durchstf 5 ml
- Market launch
- 31/03/2016
- Narcotic (BTM)
- No